Delivery Order SPE2DB20D1050-SPE2DB24FH45H

Award Date 1/8/24
Potential Completion Date 1/9/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,816,842 units of Epinephrine 0.3 mg auto-injectors. The $3,792.76 contract has a performance period through March 1, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor providing pharmaceutical products and...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,971 units of 0.3 mg epinephrine auto-injectors. The $1,196.24 delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the...
The U.S. Defense Logistics Agency (DLA) has awarded a $8,889.51 firm fixed price delivery order (SPE2DB22D1106|SPE2DB24FEKD8) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the delivery of 4,564,185,884 units of EPINEPHRINE 0.3 MG AUTO-INJECT 2S. The delivery order, which does not have a set-aside designation, has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp serves as the prime contractor for this award and holds a larger...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the procurement of 4,564,205,149 units of the EPINEPHRINE 0.3 MG AUTO-INJECT 2S medical product. The contract has a ceiling value of $23,580.31 and a performance period through April 9, 2024. This award is a standalone delivery order and not associated with any larger contract vehicle. The contract does not have a set-aside...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,089,587 units of Epinephrine 0.3 mg auto-injector devices. The $4,485.90 award has a completion date of March 28, 2024 and does not utilize a set-aside designation. AmerisourceBergen Drug Corp holds a $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical as the prime...
The U.S. Defense Logistics Agency (DLA) awarded a $1,864.07 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide 4,564,286,757 units of EPINEPHRINE 0.3 MG AUTO-INJECT 2S. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00, through which Amerisourcebergen supplies a comprehensive range of pharmaceutical products and medical supplies to support the Department of...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,592.15 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,727,625 units of Epinephrine 0.3 mg auto-injector 2-packs. The contract has a firm fixed price and an ultimate completion date of December 17, 2024. AmerisourceBergen, a for-profit organization registered in the System for Award Management (SAM.gov), is the prime contractor with no set-aside designation...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,198,118 units of EPINEPHRINE 0.3 MG AUTO-INJECT 2S. The $7,206.26 delivery order has a completion date of December 29, 2023. Amerisourcebergen Drug Corp, as a prime contractor, has received numerous contracts from DLA Troop Support Medical to supply pharmaceuticals, medical supplies, and...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,356,633 units of 0.3 mg epinephrine auto-injectors. The $3,860.83 contract has a completion date of January 19, 2024. AmerisourceBergen Drug Corp is a prime contractor providing pharmaceutical products and services to U.S. government agencies, primarily the Department of Defense. This delivery order is part of DLA Troop...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,556,651 units of 0.3 mg epinephrine auto-injectors. The $2,903.70 contract has a completion date of February 6, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations. This delivery order is issued under an indefinite delivery contract (IDC) valued at up to $999,999,999.00 with...
  • SPE2DB20D1050
    Indefinite Delivery Contract
  • SPE2DB20D1050-SPE2DB24FH45H
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,265,621 units of EPINEPHRINE 0.3 MG AUTO-INJECT 2S. The $1,291.00 delivery order is part of a larger, open-ended contract with DLA Troop Support Medical to supply pharmaceuticals and medical supplies in support of military treatment programs and facilities. No set-aside designation was used for this award, which is scheduled for completion by January 9, 2024. AmerisourceBergen Drug Corp, a for-profit organization, has a long history of federal contract awards from agencies such as the Department of Defense and Department of Justice to deliver a range of pharmaceutical products and medical materials.

Generated 4/8/24, 9:47 AM